These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25169215)

  • 21. Phytochemical and molluscicidal investigations of Fagonia arabica.
    El-Wakil EA
    Z Naturforsch C J Biosci; 2007; 62(9-10):661-7. PubMed ID: 18069237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic activity of plants of family zygophyllaceae and euphorbiaceae.
    Dastagir G; Hussain F
    Pak J Pharm Sci; 2014 Jul; 27(4):801-5. PubMed ID: 25015443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.
    Singh S; Roy S; Sethi S; Benjamin B; Sundaram S; Khanna V; Kandalkar SR; Pal C; Kant R; Patra AK; Rayasam G; Mittra S; Saini KS; Paliwal J; Chugh A; Ahmed S; Sattigeri J; Cliff I; Ray A; Bansal VS; Bhatnagar PK; Davis JA
    Eur J Pharmacol; 2011 Feb; 652(1-3):157-63. PubMed ID: 20540938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic Profiling and Investigation of the Modulatory Effect of
    Kamran S; Anwar R; Noor A; Ullah MI; Bagalagel AA; Aldurdunji MM; Ishtiaq S
    Antioxidants (Basel); 2023 Jan; 12(1):. PubMed ID: 36670981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of pyrrolidine-2-carbonitrile and 4-fluoropyrrolidine-2-carbonitrile derivatives as dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes.
    Wang J; Feng Y; Ji X; Deng G; Leng Y; Liu H
    Bioorg Med Chem; 2013 Dec; 21(23):7418-29. PubMed ID: 24153396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel long acting DPP-IV inhibitor PKF-275-055 stimulates β-cell proliferation resulting in improved glucose homeostasis in diabetic rats.
    Akarte AS; Srinivasan BP; Gandhi S
    Biochem Pharmacol; 2012 Jan; 83(2):241-52. PubMed ID: 22015634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Constituents of
    Kim BR; Paudel SB; Nam JW; Jin CH; Lee IS; Han AR
    Molecules; 2020 Sep; 25(19):. PubMed ID: 32977609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-amylase inhibitory activity of two Anthocleista species and in vivo rat model anti-diabetic activities of Anthocleista djalonensis extracts and fractions.
    Olubomehin OO; Abo KA; Ajaiyeoba EO
    J Ethnopharmacol; 2013 Apr; 146(3):811-4. PubMed ID: 23422334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating Khaya senegalensis for Dipeptidyl Peptidase-IV Inhibition Using in Vitro Analysis and Molecular Dynamic Simulation of Identified Bioactive Compounds.
    Idoko VO; Sulaiman MA; Adamu RM; Abdullahi AD; Tajuddeen N; Mohammed A; Inuwa HM; Ibrahim MA
    Chem Biodivers; 2023 Feb; 20(2):e202200909. PubMed ID: 36565063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554.
    Maezaki H; Banno Y; Miyamoto Y; Moritoh Y; Asakawa T; Kataoka O; Takeuchi K; Suzuki N; Ikedo K; Kosaka T; Sasaki M; Tsubotani S; Tani A; Funami M; Yamamoto Y; Tawada M; Aertgeerts K; Yano J; Oi S
    Bioorg Med Chem; 2011 Aug; 19(15):4482-98. PubMed ID: 21741847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Further saponins from Fagonia cretica.
    Abdel-Khalik SM; Miyase T; Melek FR; el-Ashaal HA
    Pharmazie; 2001 Mar; 56(3):247-50. PubMed ID: 11265595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihaemorrhagic potentials of Fagonia cretica against Naja naja karachiensis (black Pakistan cobra) venom.
    Razi MT; Asad MH; Khan T; Chaudhary MZ; Ansari MT; Arshad MA; Saqib QN
    Nat Prod Res; 2011 Dec; 25(20):1902-7. PubMed ID: 21656416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
    Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ephedrine as a lead compound for the development of new DPP-IV inhibitors.
    Ojeda-Montes MJ; Ardid-Ruiz A; Tomás-Hernández S; Gimeno A; Cereto-Massagué A; Beltrán-Debón R; Mulero M; Garcia-Vallvé S; Pujadas G; Valls C
    Future Med Chem; 2017 Dec; 9(18):2129-2146. PubMed ID: 29172693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel DPP-4 inhibitors against diabetes.
    Liu Y; Hu Y
    Future Med Chem; 2014 May; 6(7):793-808. PubMed ID: 24941873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.
    Tajima A; Yamamoto K; Kozakai A; Okumura-Kitajima L; Mita Y; Kitano K; Jingu S; Nakaike S
    Eur J Pharmacol; 2011 Mar; 655(1-3):99-107. PubMed ID: 21262219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dipyrrole derivative from
    Prasannaraja C; Kamalanathan AS; Vijayalakshmi MA; Venkataraman K
    Prep Biochem Biotechnol; 2020; 50(5):511-520. PubMed ID: 31910723
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis, evaluation and molecular docking of thiazolopyrimidine derivatives as dipeptidyl peptidase IV inhibitors.
    Sharma M; Gupta M; Singh D; Kumar M; Kaur P
    Chem Biol Drug Des; 2012 Dec; 80(6):918-28. PubMed ID: 22943413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure activity relationship modelling of milk protein-derived peptides with dipeptidyl peptidase IV (DPP-IV) inhibitory activity.
    Nongonierma AB; FitzGerald RJ
    Peptides; 2016 May; 79():1-7. PubMed ID: 26988873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterisation of peptides from a boarfish (Capros aper) protein hydrolysate displaying in vitro dipeptidyl peptidase-IV (DPP-IV) inhibitory and insulinotropic activity.
    Harnedy-Rothwell PA; McLaughlin CM; O'Keeffe MB; Le Gouic AV; Allsopp PJ; McSorley EM; Sharkey S; Whooley J; McGovern B; O'Harte FPM; FitzGerald RJ
    Food Res Int; 2020 May; 131():108989. PubMed ID: 32247474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.